Ineffectiveness of pulmonary irradiation in the treatment of leukemic blast crisis

TO THE EDITOR
We report a patient with acute myeloid leukemia (AML) who received radiation therapy to the lungs for the treatment of pulmonary leukostasis. A 65-year-old male was admitted with a history of fatigue, shortness of breath and newly diagnosed acute leukemia. He had a past history of myelodysplastic syndrome. He was hypoxemic with a PO2 of 46 mm Hg on room air. Initial laboratory evaluation revealed hemoglobin 8.0 gm/dl, white blood cell count (WBC) 424 500 × 10 9 /l with 30% undifferentiated blasts, and platelet count 66 000 × 10 9 /l. Bone marrow was 95% cellular with 46% blasts and was diagnostic of AML, M2 subtype. Chest radiographs showed bilateral pulmonary infiltrates. He received emergent leukapheresis and hydroxyurea. Whole brain radiation was administered on the day of admission, at a single dose of 400 cGy, using opposed lateral fields. After the first leukapheresis procedure, WBC count decreased to 251 000 × 10 9 /l. He was also treated with 150 cGy pulmonary radiation (single dose, using anterior-posterior fields), delivered to both lungs in an attempt to treat severe leukostasis. There was no improvement in his oxygenation or respiratory status. He had continued clinical deterioration and died the next day of progressive respiratory failure.
Pulmonary leukostasis is the single worst prognostic factor in patients with acute myeloid leukemia who present with hyperleukocytosis (WBC Ͼ100 000 × 10 9 /l. 1 Patients who present with hyperleukocytosis have a high risk of developing leukostasis in the lungs and brain due to occlusion of small arteries by circulating blasts.
1,2 The presence of pulmonary or cerebral leukostasis is often fatal and defines the syndrome of leukemic blast crisis. 2, 3 Heart failure and priapism can also occur. Treatment for this syndrome is with emergent leukapheresis and hydroxyurea, followed by induction chemotherapy if possible. Prophylactic whole brain radiation to Correspondence: SV Rajkumar; Fax: 507 284 1803 Received 5 November 1997; Accepted 2 July 1998 decrease the risk of cerebral hemorrhage has been used in some centers. However, evidence for these aggressive measures is anecdotal, and come only from case series and case reports.
To improve outcome after established pulmonary leukostasis, three case reports describe the success with the use of radiation therapy to both lungs. [3] [4] [5] However, all three patients in these reports were young, aged 25-29. Our patient was older, and is probably more representative of the majority of patients who present in blast crisis. He did not derive any clinical benefit from pulmonary radiation. Although our patient may have been very ill and may not have had time to gain benefit from radiation, it is our opinion that this is true of most patients with leukemic blast crisis. In fact, we feel that the three successfully treated patients in earlier reports were highly selected cases and doubt that pulmonary radiation will be of value to most patients who present with leukemic blast crisis.
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